cilostamide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, E | 1 |
| Lee, R | 1 |
| Near, R | 1 |
| Weintraub, L | 1 |
| Wolda, S | 1 |
| Lerner, A | 1 |
1 other study available for cilostamide and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Apoptosis; Blotting, Northern; Blotting, Western; Cell Line; Cy | 2002 |